Single once daily darunavir (Prezista®) 800mg tablet approved in EU

Source: BioSpace Area: News The European Commission has approved a new darunavir (Prezista®) 800mg tablet allowing patients to take one darunavir tablet once a day (in combination with other antiretrovirals for the treatment of HIV-1 infection in treatment-experienced and treatment-naïve patients with no darunavir resistance-associated mutations). This new tablet strength allows patients taking darunavir once daily to reduce the number of darunavir tablets by half.
Source: NeLM - News - Category: Drugs & Pharmacology Source Type: news